Cresco Labs (CRLBF) Cash & Current Investments (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Cash & Current Investments came in at $63.6 million in Q1 2026, up 1709.65% YoY from $3.5 million in Q1 2025, and down 30.21% on a QoQ basis from $91.1 million in Q4 2025.
Cresco Labs (CRLBF) Cash & Current Investments (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Cash & Current Investments data on file, last reported at $63.6 million in Q1 2026.
- Quarterly Cash & Current Investments rose 1709.65% year-over-year to $63.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.6 million (up 431.64% YoY) and the FY2025 annual result came in at $91.1 million, up 2548.62% from the prior year.
- Cash & Current Investments retreated to $63.6 million in Q1 2026, from $91.1 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $228.7 million in Q1 2022 to a low of $1.7 million in Q1 2024.
- A 5-year average of $59.7 million and a median of $33.3 million in 2025 frame the typical range for Cash & Current Investments.
- The widest YoY moves for Cash & Current Investments: up 2548.62% in 2025, down 97.28% in 2025.
- Tracing CRLBF's Cash & Current Investments over 5 years: stood at $228.7 million in 2022, then sank by 52.55% to $108.5 million in 2023, then tumbled by 96.83% to $3.4 million in 2024, then soared by 2548.62% to $91.1 million in 2025, then sank by 30.21% to $63.6 million in 2026.
- The last three Cash & Current Investments figures came in at $63.6 million (Q1 2026), $91.1 million (Q4 2025), and $33.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 164.00 Mn |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 64.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.57 Mn |
| Dec 31, 2025 | 91.09 Mn |
| Sep 30, 2025 | 33.29 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 115.95 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 108.52 Mn |
| Mar 31, 2022 | 228.70 Mn |
| Dec 31, 2021 | 5.12 Mn |
| Sep 30, 2021 | 202.41 Mn |
| Jun 30, 2021 | 135.23 Mn |
| Mar 31, 2021 | 262.44 Mn |
| Dec 31, 2020 | 29.74 Mn |
| Sep 30, 2020 | 59.62 Mn |
| Mar 31, 2020 | 70.03 Mn |
| Dec 31, 2019 | 10.10 Mn |